HIF1A and cancer: Based on these data, it is proposed that RG6016 may modulate the HIF-1α pathway via LSD1, UCHL1, and MYC in aggressive cancers such as SCLC, thereby influencing key processes like hypoxia response, metastasis, and neuroendocrine differentiation.